Neovasc Inc. (TSE:NVC – Get Free Report) (NASDAQ:NVCN)’s stock price rose 2.3% during mid-day trading on Monday . The company traded as high as C$1.82 and last traded at C$1.78. Approximately 46,869 shares were traded during mid-day trading, a decline of 58% from the average daily volume of 111,876 shares. The stock had previously closed at C$1.74.
Neovasc Price Performance
The firm has a 50 day moving average of C$1.78.
About Neovasc
Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.
Featured Stories
- Five stocks we like better than Neovasc
- How to Read Stock Charts for Beginners
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- Retail Stocks Investing, Explained
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.
